Biomarkers in Prediction of AMI

University of Tartu250 enrolled

Overview

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

250

Conditions

Acute Mesenteric Ischemia

Interventions

Sequential blood samplesDIAGNOSTIC_TEST

Sequential blood samples for diagnostic tests is the only intervention in thei study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 years or older * Initial decision in favour of further diagnostics of mesenteric ischaemia Exclusion Criteria: * Age \<18 years * Consent declined by patient or next of kin (delayed consent) * Chronic mesenteric ischaemia without an acute event * Immediate decision for withdrawal of further diagnostics and active treatment * Referral from another hospital with already established diagnosis of AMI * AMI diagnosed at surgery without previously having been considered

Locations (2)

Tartu University Hospital

Tartu, Estonia

RECRUITING

Lucerne Cantonal Hospital

Lucerne, Switzerland

RECRUITING

Outcomes

Primary Outcomes

Rate of correctly predicted cases of acute mesenteric ischaemia

Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers

Time frame: 10 months

Central Contacts

Annika Reintam Blaser, PhD

CONTACT

+3725142281 annika.reintam.blaser@ut.ee

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.